Page results
-
This page is for patients having planned neurosurgery.
-
Patient information for patients undergoing Image Rehearsal Therapy (IRT).
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
We provide a specialist service for the assessment and treatment of sarcoidosis as part of the interstitial lung disease (ILD) service at UCLH. We provide holistic multidisciplinary care, with a weekly consultant-led outpatient clinic and clinical nurse specialist support.
-
We offer an expert service for complex pulmonary embolic disease (PED) and follow up for all cases diagnosed with this condition at UCLH.
-
We provide a comprehensive service from early diagnosis to advanced treatments for severe COPD. We have a strong multidisciplinary team (MDT) including doctors, specialist nurses, physiotherapists, physiologists and psychologists, which enables us to provide holistic, personalised care to each of our patients.
-
This page is for patients who are receiving radiotherapy to the bladder.
-
Enhanced supportive care is specialist care that aims to manage and minimise pain and other symptoms caused by cancer or cancer treatment.
-
Oropharyngeal cancer is a type of cancer that affects the part of the throat at the back of the mouth.
-
UCLH provides a comprehensive service to diagnose, treat and support people with cancer. We are a specialist centre for many types of cancer and treat patients from both our local area and across the country.
File results
-
FOI/2023/0295 - Strikes and Trust use of the BMA rate card
-
FOI/2023/0296 - Consultant workforce information
-
FOI/2023/0300 - Post-mortem examinations for 2019, 2020, 2021 and 2022
-
FOI/2023/0301 - Meat served at the Trust that may contain nitrates or nitrites
-
FOI/2023/0303 - Sexual harassment from patients towards staff in 2022
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust